Infectious Disease Molecular Diagnostics Market (By Product: Instruments, Reagents, Services; By End-use: Hospitals, Clinics, Diagnostics Laboratories, Research Institutes; By Technology: Polymerase chain reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others; By Application) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Infectious Disease Molecular Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Infectious Disease Molecular Diagnostics Market, by Product, 2024-2033
8.1.1. Instruments
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Reagents
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2033)
9.1. Infectious Disease Molecular Diagnostics Market, by End-use, 2024-2033
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Clinics
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Diagnostics Laboratories
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Research Institutes
9.1.4.1. Market Revenue and Forecast (2021-2033)
10.1. Infectious Disease Molecular Diagnostics Market, by Technology, 2024-2033
10.1.1. Polymerase chain reaction (PCR)
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. In Situ Hybridization
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Isothermal Nucleic Acid Amplification Technology (INAAT)
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Chips and Microarrays
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Mass Spectrometry
10.1.5.1. Market Revenue and Forecast (2021-2033)
10.1.6. Sequencing
10.1.6.1. Market Revenue and Forecast (2021-2033)
10.1.7. Transcription Mediated Amplification
10.1.7.1. Market Revenue and Forecast (2021-2033)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2021-2033)
11.1. Infectious Disease Molecular Diagnostics Market, by Application, 2024-2033
11.1.1. Respiratory Diseases
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Tuberculosis
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Meningitis
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Gastrointestinal Tract Infections
11.1.4.1. Market Revenue and Forecast (2021-2033)
11.1.5. HPV
11.1.5.1. Market Revenue and Forecast (2021-2033)
11.1.6. Sexually Transmitted Infections
11.1.6.1. Market Revenue and Forecast (2021-2033)
11.1.7. Sepsis
11.1.7.1. Market Revenue and Forecast (2021-2033)
11.1.8. Drug Resistance Diseases
11.1.8.1. Market Revenue and Forecast (2021-2033)
11.1.9. Other Infectious Diseases
11.1.9.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Forecast, by End-use (2021-2033)
12.1.3. Market Revenue and Forecast, by Technology (2021-2033)
12.1.4. Market Revenue and Forecast, by Application (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Forecast, by End-use (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Technology (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Forecast, by End-use (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Technology (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Forecast, by End-use (2021-2033)
12.2.3. Market Revenue and Forecast, by Technology (2021-2033)
12.2.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Forecast, by End-use (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Technology (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Forecast, by End-use (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Technology (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Forecast, by End-use (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Technology (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Application (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Forecast, by End-use (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Technology (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Application (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Forecast, by End-use (2021-2033)
12.3.3. Market Revenue and Forecast, by Technology (2021-2033)
12.3.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Forecast, by End-use (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Technology (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Forecast, by End-use (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Technology (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Forecast, by End-use (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Technology (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Application (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Forecast, by End-use (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Technology (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Application (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Forecast, by End-use (2021-2033)
12.4.3. Market Revenue and Forecast, by Technology (2021-2033)
12.4.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Forecast, by End-use (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Technology (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Forecast, by End-use (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Technology (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Forecast, by End-use (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Technology (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Application (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Forecast, by End-use (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Technology (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Application (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Forecast, by End-use (2021-2033)
12.5.3. Market Revenue and Forecast, by Technology (2021-2033)
12.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Forecast, by End-use (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Technology (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Application (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Forecast, by End-use (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Technology (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Application (2021-2033)
13.1. Sysmex Corporation
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Siemens Healtineers AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Qiagen
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Grifols S.A.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Illumina, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Hologic, Inc. (Gen-Probe)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Becton, Dickinson and Company
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Agilent Technologies, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Bio-Rad Laboratories, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. F. Hoffmann-La Roche Ltd
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample